| ²é¿´: 1033 | »Ø¸´: 5 | |||
cxmlxmf123Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
|
[½»Á÷]
Arch Pharm. ÉÏһƪÎÄÕÂÔõô¿´²»µ½¾í¡¢ÆÚ¡¢Ò³Â룿 ÒÑÓÐ2È˲ÎÓë
|
|
¸÷λÅóÓÑ£¬±¾ÈËÓöµ½Ò»¼þ¹ÖÊ£º ÎÒÏëÒýÓÃarch pharm. ÉÏһƪÎÄÕÂ×öΪ²Î¿¼ÎÄÏ×£¬¿ÉËÖª£¬×óÕÒÓÒÕÒ¾ÍÊÇÕÒ²»µ½ÕâÆªÎÄÕÂµÄ¾í¡¢ÆÚ¡¢Ò³Âë¡£¿ÒÇëÅóÓÑÃǰïÖúһϣ¡ ÕâÆªÎÄÕµÄdoiºÅÈçÏ£º https://doi.org/10.1002/ardp.202000008 ÔÚÕâÆªÎÄÕµÄÕýÎÄ×î϶ˣ¬Ö»Ð´ÁËÕâÑùÒ»¾ä»°: how to cite this article: acar Çevik u, sağlık bn, osmaniye d, et al. synthesis and docking study of benzimidazole¨ctriazolothiadiazine hybrids as aromatase inhibitors. arch pharm. 2020;e2000008. https://doi.org/10.1002/ardp.202000008 |
» ²ÂÄãϲ»¶
½ñÈÕ²»·Å°ñ£¿Íø´«¹ú×ÔȻԤ¼Æ 8 Ô 27 Èտɲé½á¹û
ÒѾÓÐ21È˻ظ´
ÄÜ·ñÍ˳ö²ÎÓëµÄÃæÉÏÏîÄ¿½â³ýÏÞÏî
ÒѾÓÐ17È˻ظ´
¹À¼ÆÊÇÖÜËÄ
ÒѾÓÐ4È˻ظ´
ÎÒÃæÉÏÍêµ°ÁË
ÒѾÓÐ9È˻ظ´
2026¹ú×ÔÈ»º¯ÆÀ·Ñµ½ÕË
ÒѾÓÐ18È˻ظ´
½¨Òé»ù½ð·¢²¼Ìáǰ¸ø³öÃ÷È·µÄʱ¼äµã
ÒѾÓÐ15È˻ظ´
·¶½øÖоÙÒ»ÎĵÄÖÐÐÄ˼Ïë
ÒѾÓÐ7È˻ظ´
ÅóÓÑȦ¿´µ½µÄ
ÒѾÓÐ9È˻ظ´
ÈÃÎÒÖÐÒ»¸öÃæÉϰɣ¡
ÒѾÓÐ16È˻ظ´
·Å°ñǰµÄ²»µ¶¨
ÒѾÓÐ17È˻ظ´

aspect3000
ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 190 (¸ßÖÐÉú)
- ½ð±Ò: 35339.7
- É¢½ð: 955
- ºì»¨: 57
- ɳ·¢: 3
- Ìû×Ó: 7743
- ÔÚÏß: 1208.4Сʱ
- ³æºÅ: 44782
- ×¢²á: 2004-05-01
- רҵ: Óлú·ÖÎö
2Â¥2020-12-10 05:35:45
cxmlxmf123
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 8893.9
- É¢½ð: 49
- ºì»¨: 10
- Ìû×Ó: 5377
- ÔÚÏß: 719.9Сʱ
- ³æºÅ: 355544
- ×¢²á: 2007-04-25
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É

3Â¥2020-12-10 08:02:47
Tookov
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 75
- Ìû×Ó: 13
- ÔÚÏß: 18.7Сʱ
- ³æºÅ: 2188550
- ×¢²á: 2012-12-15
- רҵ: Óлú»¯Ñ§
¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
|
Archiv der Pharmazie Volume 353, Issue 5 ·¢×ÔСľ³æAndroid¿Í»§¶Ë |
4Â¥2020-12-21 02:00:25
Tookov
Ìú³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 75
- Ìû×Ó: 13
- ÔÚÏß: 18.7Сʱ
- ³æºÅ: 2188550
- ×¢²á: 2012-12-15
- רҵ: Óлú»¯Ñ§
5Â¥2020-12-21 02:02:38
cxmlxmf123
Ìú¸Ëľ³æ (ÖªÃû×÷¼Ò)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 8893.9
- É¢½ð: 49
- ºì»¨: 10
- Ìû×Ó: 5377
- ÔÚÏß: 719.9Сʱ
- ³æºÅ: 355544
- ×¢²á: 2007-04-25
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É

6Â¥2020-12-21 07:34:08









»Ø¸´´ËÂ¥